Literature DB >> 29882078

Dosimetric comparison between realistic ocular model and other models for COMS plaque brachytherapy with 103Pd, 131Cs, and 125I radioisotopes.

Atiyeh Ebrahimi-Khankook1, Alireza Vejdani-Noghreiyan2.   

Abstract

Nowadays, Monte Carlo calculations are commonly used for the evaluation of dose distributions and dose volume histograms in eye brachytherapy. However, currently available eye models have simple geometries, and main substructures of the eye are either not defined in details or not distinguished at all. In this work absorbed doses of eye substructures have been estimated for eye plaque brachytherapy using the most realistic eye model available, and compared with absorbed doses obtained with other available eye models. For this, a medium-sized tumour on the left sides of the right eye was considered. Dosimetry calculations were performed for four different eye models developed based on a literature review, and using a 12 mm Collaborative Ocular Melanoma Study plaque containing 131Cs, 103Pd, and 125I sources. Obtained results illustrate that the estimated doses received by different eye substructures strongly depend on the model used to represent the eye. It is shown here that using a non-realistic eye model leads to a wrong estimation of doses for some eye substructures. For example, dose differences of up to 35% were observed between the models proposed by Nogueira and co-workers and Yoriyaz and co-workers, while doses obtained by use of the models proposed by Lesperance and co-workers, and Behrens and co-workers differed up to 100 and 63% as compared to the situation when a realistic model was used, respectively. Moreover, comparing different radionuclides showed that the most uniform dose distribution in the considered tumour region was that from 131Cs, with a coefficient of variation of 33%. In addition, considering the realistic eye model, it was found that the radiosensitive region of the lens received more than the threshold dose of cataract induction (0.5 Gy), for all investigated radionuclides.

Entities:  

Keywords:  Brachytherapy; Dosimetry; MCNP code; Realistic eye model

Mesh:

Substances:

Year:  2018        PMID: 29882078     DOI: 10.1007/s00411-018-0748-3

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  23 in total

1.  The effects of variations in the density and composition of eye materials on ophthalmic brachytherapy dosimetry.

Authors:  Somayeh Asadi; Seyed Farhad Masoudi; Majid Shahriari
Journal:  Med Dosim       Date:  2011-06-30       Impact factor: 1.482

Review 2.  Acute and late side effects of radiotherapy for ocular disease: an overview.

Authors:  W Alberti
Journal:  Front Radiat Ther Oncol       Date:  1997

3.  Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.

Authors:  Marielle Lesperance; M Martinov; R M Thomson
Journal:  Med Phys       Date:  2014-03       Impact factor: 4.071

4.  Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.

Authors:  Marielle Lesperance; M Inglis-Whalen; R M Thomson
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

5.  The effects of simulating a realistic eye model on the eye dose of an adult male undergoing head computed tomography.

Authors:  Parisa Akhlaghi; Atiyeh Ebrahimi-Khankook; Alireza Vejdani-Noghreiyan
Journal:  Radiat Environ Biophys       Date:  2017-03-10       Impact factor: 1.925

6.  Physical dosimetry of 125I seeds of a new design for interstitial implant.

Authors:  C C Ling; E D Yorke; I J Spiro; D Kubiatowicz; D Bennett
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-11       Impact factor: 7.038

7.  Dimensions of the human eye relevant to radiation protection.

Authors:  M W Charles; N Brown
Journal:  Phys Med Biol       Date:  1975-03       Impact factor: 3.609

8.  Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.

Authors:  Sou-Tung Chiu-Tsao; Melvin A Astrahan; Paul T Finger; David S Followill; Ali S Meigooni; Christopher S Melhus; Firas Mourtada; Mary E Napolitano; Ravinder Nath; Mark J Rivard; D W O Rogers; Rowan M Thomson
Journal:  Med Phys       Date:  2012-10       Impact factor: 4.071

9.  Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy.

Authors:  Mark K Murphy; R Kim Piper; Lawrence R Greenwood; Michael G Mitch; Paul J Lamperti; Stephen M Seltzer; Matt J Bales; Mark H Phillips
Journal:  Med Phys       Date:  2004-06       Impact factor: 4.071

10.  Comparison of 16 mm OSU-Nag and COMS eye plaques.

Authors:  Hualin Zhang; Frederick Davidorf; Yujin Qi
Journal:  J Appl Clin Med Phys       Date:  2012-05-10       Impact factor: 2.102

View more
  1 in total

1.  Development of GATE Monte Carlo Code for Simulation and Dosimetry of New I-125 Seeds in Eye Plaque Brachytherapy.

Authors:  Payvand Taherparvar; Zeinab Fardi
Journal:  Nucl Med Mol Imaging       Date:  2021-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.